{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:12:47Z","timestamp":1788487967563,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":74,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00863-8","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T18:52:21Z","timestamp":1782154341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deciphering mitotic catastrophe\u2013associated transcriptomic patterns in renal cell carcinoma: prognostic significance and immunotherapy-related associations"],"prefix":"10.1186","volume":"21","author":[{"given":"Zilin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"issue":"3","key":"863_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a. Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"Cancer J Clin"},{"issue":"10451","key":"863_CR2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0140-6736(24)00917-6","volume":"404","author":"M Young","year":"2024","unstructured":"Young M, et al. Renal cell carcinoma. Lancet (London England). 2024;404(10451):476\u201391.","journal-title":"Lancet (London England)"},{"issue":"1","key":"863_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12943-023-01911-x","volume":"23","author":"Y Wang","year":"2024","unstructured":"Wang Y, et al. Evolution of cell therapy for renal cell carcinoma. Mol Cancer. 2024;23(1):8.","journal-title":"Mol Cancer"},{"key":"863_CR4","doi-asserted-by":"crossref","unstructured":"Au L, Hatipoglu E, Robert de Massy M, Litchfield K, Beattie G, Rowan A, et al. Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma. Cancer Cell. 2021;39(11):1497-518.e11.","DOI":"10.2139\/ssrn.3813274"},{"key":"863_CR5","doi-asserted-by":"publisher","first-page":"100929","DOI":"10.1016\/j.drup.2023.100929","volume":"67","author":"J Jin","year":"2023","unstructured":"Jin J, et al. Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers. Drug Resist Updates: Reviews Commentaries Antimicrob Anticancer Chemother. 2023;67:100929.","journal-title":"Drug Resist Updates: Reviews Commentaries Antimicrob Anticancer Chemother"},{"issue":"1","key":"863_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13046-024-03079-8","volume":"43","author":"HK Rachamala","year":"2024","unstructured":"Rachamala HK, et al. Targeting mTOR and survivin concurrently potentiates radiation therapy in renal cell carcinoma by suppressing DNA damage repair and amplifying mitotic catastrophe. J Experimental Clin Cancer Research: CR. 2024;43(1):159.","journal-title":"J Experimental Clin Cancer Research: CR"},{"issue":"8","key":"863_CR7","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/s41556-025-01723-9","volume":"27","author":"A Khan","year":"2025","unstructured":"Khan A, et al. A SETD2-CDK1-lamin axis maintains nuclear morphology and genome stability. Nat Cell Biol. 2025;27(8):1327\u201341.","journal-title":"Nat Cell Biol"},{"issue":"5","key":"863_CR8","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"key":"863_CR9","volume-title":"Mechanisms generating cancer genome complexity from a single cell division error","author":"NT Umbreit","year":"2020","unstructured":"Umbreit NT, et al. Mechanisms generating cancer genome complexity from a single cell division error. Volume 368. New York, N.Y.): Science; 2020. 6488."},{"issue":"1","key":"863_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","volume":"23","author":"HK Matthews","year":"2022","unstructured":"Matthews HK, Bertoli C, de Bruin RAM. Cell cycle control in cancer. Nat Rev Mol Cell Biol. 2022;23(1):74\u201388.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"863_CR11","doi-asserted-by":"crossref","unstructured":"Mc Gee MM. Targeting the Mitotic Catastrophe Signaling Pathway in Cancer. Mediators of Inflammation, 2015. 2015: p. 146282.","DOI":"10.1155\/2015\/146282"},{"issue":"1","key":"863_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13062-021-00313-7","volume":"16","author":"EV Sazonova","year":"2021","unstructured":"Sazonova EV, et al. A link between mitotic defects and mitotic catastrophe: detection and cell fate. Biol Direct. 2021;16(1):25.","journal-title":"Biol Direct"},{"issue":"1","key":"863_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41392-024-01896-z","volume":"9","author":"Z-L Chen","year":"2024","unstructured":"Chen Z-L, et al. Synergistic induction of mitotic pyroptosis and tumor remission by inhibiting proteasome and WEE family kinases. Signal Transduct Target Therapy. 2024;9(1):181.","journal-title":"Signal Transduct Target Therapy"},{"key":"863_CR14","doi-asserted-by":"crossref","unstructured":"Denisenko TV et al. Mitotic catastrophe and cancer drug resistance: a link that must to be broken. Drug Resistance Updates: Reviews and Commentaries In Antimicrobial and Anticancer Chemotherapy, 2016. 24.","DOI":"10.1016\/j.drup.2015.11.002"},{"key":"863_CR15","doi-asserted-by":"publisher","first-page":"1409448","DOI":"10.3389\/fimmu.2024.1409448","volume":"15","author":"Z Mao","year":"2024","unstructured":"Mao Z, et al. Mitotic catastrophe heterogeneity: implications for prognosis and immunotherapy in hepatocellular carcinoma. Front Immunol. 2024;15:1409448.","journal-title":"Front Immunol"},{"key":"863_CR16","doi-asserted-by":"publisher","first-page":"e18075","DOI":"10.7717\/peerj.18075","volume":"12","author":"S Wang","year":"2024","unstructured":"Wang S, et al. Development and validation of a mitotic catastrophe-related genes prognostic model for breast cancer. PeerJ. 2024;12:e18075.","journal-title":"PeerJ"},{"issue":"1","key":"863_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13062-025-00650-x","volume":"20","author":"H Dai","year":"2025","unstructured":"Dai H, et al. Integrating machine learning models with multi-omics analysis to decipher the prognostic significance of mitotic catastrophe heterogeneity in bladder cancer. Biol Direct. 2025;20(1):56.","journal-title":"Biol Direct"},{"issue":"3","key":"863_CR18","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","volume":"55","author":"M Meylan","year":"2022","unstructured":"Meylan M, et al. Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer. Immunity. 2022;55(3):527\u2013e5415.","journal-title":"Immunity"},{"issue":"1","key":"863_CR19","doi-asserted-by":"publisher","first-page":"7973","DOI":"10.1038\/s41467-022-35553-2","volume":"13","author":"J Huang","year":"2022","unstructured":"Huang J, et al. Genomics and phenomics of body mass index reveals a complex disease network. Nat Commun. 2022;13(1):7973.","journal-title":"Nat Commun"},{"key":"863_CR20","doi-asserted-by":"crossref","unstructured":"Prokhorova EA et al. The DNA-damage response and nuclear events as regulators of nonapoptotic forms of cell death. Oncogene, 2020;39(1):1\u201316.","DOI":"10.1038\/s41388-019-0980-6"},{"issue":"2","key":"863_CR21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1001\/jamaoncol.2021.4337","volume":"8","author":"V Navani","year":"2022","unstructured":"Navani V, Heng DYC. Treatment Selection in First-line Metastatic Renal Cell Carcinoma-The Contemporary Treatment Paradigm in the Age of Combination Therapy: A Review. JAMA Oncol. 2022;8(2):292\u20139.","journal-title":"JAMA Oncol"},{"key":"863_CR22","doi-asserted-by":"crossref","unstructured":"Vitale I et al. Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol. 2011;12(6):85\u201392.","DOI":"10.1038\/nrm3115"},{"key":"863_CR23","doi-asserted-by":"crossref","unstructured":"Orth JD, Loewer A, Lahav G, Mitchison TJ. Prolonged mitotic arrest triggers partial activation of apoptosis, resulting in DNA damage and p53 induction. Mol Biol Cell. 2012;23(4):567\u201376.","DOI":"10.1091\/mbc.e11-09-0781"},{"issue":"3","key":"863_CR24","first-page":"153","volume":"13","author":"M Carbone","year":"2013","unstructured":"Carbone M, et al. BAP1 cancer. 2013;13(3):153\u20139.","journal-title":"BAP1 cancer"},{"issue":"4","key":"863_CR25","first-page":"950","volume":"166","author":"IY Park","year":"2016","unstructured":"Park IY, et al. Dual chromatin cytoskeletal remodeling SETD2. 2016;166(4):950\u201362.","journal-title":"Dual chromatin cytoskeletal remodeling SETD2"},{"issue":"9","key":"863_CR26","first-page":"1884","volume":"18","author":"Z Li","year":"2017","unstructured":"Li Z. X.J.I.j.o.m.s. Zhang. Kinases involved both autophagy mitosis. 2017;18(9):1884.","journal-title":"Kinases involved both autophagy mitosis"},{"key":"863_CR27","doi-asserted-by":"crossref","unstructured":"Odle RI, Walker SA, Oxley D, Kidger AM, Balmanno K, Gilley R, et al. An mTORC1-to-CDK1 switch maintains autophagy suppression during mitosis. Mol Cell. 2020;77(2):228\u201340.e7.","DOI":"10.1016\/j.molcel.2019.10.016"},{"key":"863_CR28","doi-asserted-by":"publisher","first-page":"1109378","DOI":"10.3389\/fonc.2023.1109378","volume":"13","author":"L Wei","year":"2023","unstructured":"Wei L, et al. CCNF is a potential pancancer biomarker and immunotherapy target. Front Oncol. 2023;13:1109378.","journal-title":"Front Oncol"},{"key":"863_CR29","doi-asserted-by":"crossref","unstructured":"Chang SC, et al. A novel signature of CCNF-associated E3 ligases collaborate and counter each other in breast cancer. Cancers (Basel). 2021;13(12):2873.","DOI":"10.3390\/cancers13122873"},{"issue":"13","key":"863_CR30","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.7150\/jca.86597","volume":"14","author":"X Gao","year":"2023","unstructured":"Gao X, et al. A Comprehensive Analysis of the Prognostic, Immunological and Diagnostic Role of CCNF in Pan-cancer. J Cancer. 2023;14(13):2431\u201342.","journal-title":"J Cancer"},{"issue":"6","key":"863_CR31","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.cell.2018.08.027","volume":"174","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum SF, Cantley LC. The Multifaceted Role of Chromosomal Instability in Cancer and Its Microenvironment. Cell. 2018;174(6):1347\u201360.","journal-title":"Cell"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00863-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00863-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00863-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:26:25Z","timestamp":1788485185000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00863-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["863"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00863-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8876859\/v1","asserted-by":"object"}]},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"14 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The studies were conducted in accordance with the Declaration of Helsinki and the International Conference on Harmonization (ICH) Guidelines for Good Clinical Practice. Approval for the use of patient samples (No. 2021\u2009\u2212\u2009161) was granted by the Ethics Committee of West China Hospital. Written informed consent was obtained from all participating patients. All animal experiments were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of West China Hospital (No. 20240510004) and were conducted in accordance with the approved protocol and relevant national and institutional guidelines for the care and use of laboratory animals. According to the approved protocol, the maximal permitted tumor burden was 1,500 mm\u00b3 (or a maximal diameter of 15 mm).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent for the publication of anonymized data and images. The consent forms are held by the authors\u2019 institution and are available for review by the journal upon reasonable request.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"At no time did tumor size exceed the approved maximum.","order":3,"name":"Ethics","label":"Tumor size","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"167"}}